genome analysis
NantHealth Q1 Revenues Decline 11 Percent
NantHealth reported a net loss of $15.4 million during the quarter, as sequencing and molecular analysis revenues fell to just $3,000.
NantHealth Q4 Revenues Flat From Year Ago
The firm posted total software-related revenues of $18.6 million, up 1 percent from $18.4 million in Q4 2019.
Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing
University of Glasgow spinout Gabriel Precision Oncology will contribute a bioinformatics pipeline derived from cancer tissue samples to accelerate MDx adoption.
NantHealth Q3 Revenues Tick Up Slightly
The health IT and precision oncology arm of Patrick Soon-Shiong's NantWorks conglomerate narrowed its quarterly net loss by 32 percent during the quarter.
ESHG, ACMG Differ Starkly in Recommendations for Reporting Secondary Findings From Genomic Tests
During a session at the ASHG 2020 virtual meeting, representatives from both organizations laid out the reasons for their contrasting guidelines.
Aug 6, 2020
NantHealth Q2 Revenues Decline 12 Percent
Apr 30, 2019
Congenica Raises £13.3M in Series B Add-On
Mar 27, 2018